Pharmaceutical composition for treatment of allergic reactions

作者: Thomas Dr. Grunwald , Carsten B. Prof.Dr. Schmidt-Weber

DOI:

关键词:

摘要: The invention relates to a pharmaceutical composition made of one or more preparations and comprising physiologically effective dose at least IL-4 and/or IL-13 inhibitor allergene, matrix, wherein the is solved embedded, whereon coated adsorbed, matrix selected as enable prolonged release inhibitor.

参考文章(77)
M. Famulok, G. Mayer, Aptamers as Tools in Molecular Biology and Immunology Current Topics in Microbiology and Immunology. ,vol. 243, pp. 123- 136 ,(1999) , 10.1007/978-3-642-60142-2_7
Amy C Yan, Kathryn M Bell, Megan M Breeden, Andrew D Ellington, Aptamers: prospects in therapeutics and biomedicine Frontiers in Bioscience. ,vol. 10, pp. 1802- 1827 ,(2005) , 10.2741/1663
Cohava Gelber, Anthony Cerami, Carla Cerami, David Dove, Methods and devices for modulating the immune response ,(2004)
Ho-Yuan Chou, Xi-Zhang Lin, Wen-Yu Pan, Ping-Yi Wu, Chia-Ming Chang, Tsai-Yu Lin, Hsin-Hsin Shen, Mi-Hua Tao, Hydrogel-Delivered GM-CSF Overcomes Nonresponsiveness to Hepatitis B Vaccine through the Recruitment and Activation of Dendritic Cells Journal of Immunology. ,vol. 185, pp. 5468- 5475 ,(2010) , 10.4049/JIMMUNOL.1001875
Jeffrey M. Greve, Armen B. Shanafelt, Steven Roczniak, DNA encoding high affinity interleukin-4 muteins ,(1999)
Pierre-Yves Mantel, Nadia Ouaked, Beate Rückert, Christian Karagiannidis, Roland Welz, Kurt Blaser, Carsten B. Schmidt-Weber, Molecular Mechanisms Underlying FOXP3 Induction in Human T Cells Journal of Immunology. ,vol. 176, pp. 3593- 3602 ,(2006) , 10.4049/JIMMUNOL.176.6.3593
Edzard Dr. Spillner, Reinhard Prof.Dr. Bredehorst, Thomas Dr. Grunwald, Mark Dipl.-Chem. Matzas, Jörn Dr. Glökler, Method for determining an unknown PNA sequence and uses thereof ,(2005)